Lexaria Bioscience Corp. (LEXX)
NASDAQ·Healthcare·Biotechnology
$4.50
+7.91%
Mkt Cap $14.10M
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$1.50
Range $1.50 – $1.50
Implied Upside
-66.7%
Consensus $1.50 vs current $4.50
NASDAQ·Healthcare·Biotechnology
$4.50
+7.91%
Mkt Cap $14.10M
No recent rating data.
Price Target (1 analysts)
$1.50
Range $1.50 – $1.50
-66.7%
Consensus $1.50 vs current $4.50